ClinicalTrials.gg
TerminatedNCT03275246X-PSIUpdated Oct 6, 2021Results posted

Establish Implant Accuracy With X-PSI Knee System

An interventional study of X-PSI Knee System in Knee Osteoarthritis and Post-traumatic Osteoarthritis, sponsored by Zimmer, GmbH. Terminated at 4 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-06.

Sponsored by Zimmer, GmbH · Not applicable, Interventional, and Treatment

Why this study was terminated
The clinical study was stopped due to very low enrolment numbers. Due to the very slow enrolment, the goal of the study cannot be reached within a reasonable time frame.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 24 studies in Osteoarthritis, Knee by Zimmer Biomet — 1 open to participants now, 5 under way, none of them phase 3. Osteoarthritis, Knee · Zimmer Biomet.

Enrollment
16th of 17
8 · median 93
Started
2018
with 1 other
No phase
16 of 24
none open now
Registered
15th of 24
by date

Among the 24 studies in Osteoarthritis, Knee by Zimmer Biomet, this one is the 16th largest by enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2018, is one of 16 with no phase, and was the 15th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 624 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

1 of the 24 studies in Osteoarthritis, Knee by Zimmer Biomet is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Who these studies take

Of the 385 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 114 (30%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Osteoarthritis, Knee by Zimmer Biomet, or all of them as a file.
02

Study summary

The goal of this study is to establish the accuracy of the new X-PSI Knee System guides by analyzing early postoperative (4-6 weeks) imaging data with regards to the mechanical alignment and compare them with preoperative planning imaging data. Mechanical alignment in the hip-knee-ankle (HKA) frontal plane with X-PSI Knee System will be measured and compared with results reported in the literature using a conventional (non-guided) approach.

Hypothesis: The use of the new X-PSI Knee System achieves the same accuracy with respect to mechanical alignment as with conventional instrumentation.

Read the detailed description

Patient-specific instruments (PSI) provide surgeons with an anatomically personalized surgery tool. The newly developed and CE-marked X-PSI Knee System is based on long leg x-rays that are used to generate a pre-operative 3D model of the knee. The total knee replacement surgery will be planned according to this 3D model.

The aim of this multi-center, prospective, non-controlled post-market study is to scientifically document the accuracy, cost-effectiveness and subsequent clinical performance of the X-PSI Knee System. The X-PSI pin guides are designed to facilitate a more simplified, efficient and customized TKA procedure compared to conventional, non-guided instrumentation.

To evaluate the accuracy of the X-PSI Knee System, early postoperative (4-6 weeks) imaging data will be analysed with regards to the mechanical alignment (hip-knee-ankle angle) of the leg and matched to preoperative planning imaging data. The X-PSI Knee System cohort will then be compared with current literature (70% of cases within ±3 degrees) where patients were conventionally operated with non-guided surgery. No control group will be studied.

The cost-effectiveness of the X-PSI Knee System will be evaluated with an efficiency matrix to record OR set-up time, surgery time and post-processing time.

Clinical outcome data of the patients will be evaluated 4-6 weeks and 1 year post-surgery with the help of patient questionnaires (VAS pain scale, EQ-5D and Oxford Knee Score), a physical exam and the assessment of radiographs.

The study population will be compromised of males and females requiring total knee arthroplasty and satisfy the inclusion/exclusion criteria. The study will last one (1) year from the time of surgery. The collected data aim to improve the treatment and quality of life of patients suffering from degenerative joint diseases. In addition, shorter surgery times possibly result in reduced risk of infection, decreased time of anaesthesia and better cost-effectiveness.

03

Conditions studied

  • Knee Osteoarthritis
  • Post-traumatic Osteoarthritis

Keywords

  • Primary total knee replacement
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient is 18 years of age or older.
  • Patient can follow the X-PSI Knee System imaging protocol as part of standard of care procedures.
  • Patient gets TKA treatment which follows the criteria of the appropriate Instruction for Use.
  • Patient is willing and able to cooperate in the required postoperative standard of care.
  • Patient is willing and able to complete scheduled follow-up evaluations as described in the .
  • Patient has participated in the study-related Informed Consent process and has signed the Ethics Committee approved Informed Consent

Exclusion criteria

Exclusion Criteria:

  • Patient is unwilling or unable to give consent or to comply with the follow-up program.
  • Patient meets exclusion criteria of the appropriate Instruction for Use
  • Patients who have any condition which would in the judgement of the Investigator place the patient at undue risk or interfere with the study. Any patient who is institutionalized, or is a known drug abuser, a known alcoholic or anyone who cannot understand what is required from them
  • Patient is known to be pregnant
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    Total knee arthroplasty

    Patients undergoing total knee arthroplasty

    Device: X-PSI Knee System

Interventions

  • DeviceX-PSI Knee System

    Patients are operated with X-PSI Knee System guides

06

What researchers measure

Primary outcomes

  1. Mechanical Leg Alignment

    Achievement of mechanical leg alignment in HKA frontal plane (± 3 degrees) with X-PSI Knee System is as accurate as with standard instrumentation at 4-6 weeks post operation. The X-PSI Knee System cohort will be compared with current literature (70% of cases within ± 3 degrees). No control group will be studied.

    Time frame: 4-6 weeks post-surgery

Secondary outcomes

  1. Cost-effectiveness of the X-PSI Knee System Using an Efficiency Matrix

    The cost-effectiveness of the X-PSI Knee System will be measured using an efficiency matrix where OR set-up time, surgery time and tray sterilization times will be collected and compared to conventional TKA procedures.

    Time frame: During surgery, immediate pre- and post-surgery processing time

Other outcomes

  1. Patient Clinical Outcome Measure: Visual Analog Score Pain

    Obtain clincal outcome data on patients treated using the X-PSI Knee System in primary TKA procedures. The pain level will be measured using a 10 cm long scale indicating no pain (0) and worst imaginable pain (10).

    Time frame: Baseline, 4-6 weeks and 1 year post-surgery

  2. Patient Clinical Outcome Measure: Oxford Knee Score

    The Oxford Knee Score (OKS) is a 12-item patient-reported patient reported outcome specifically designed and developed to assess function and pain after total knee replacement (TKR) surgery (arthroplasty). The OKS provides a single summed score which reflects the severity of problems that the respondent has with their knee. Each question (item) is scored from 0 to 4 with 0 being the worst outcome and 4 being the best outcome. The scores are then summed to produce an overall score running from 0 (worst possible) to 48 (best outcome).

    Time frame: Baseline, 4-6 weeks and 1 year post-surgery

  3. Patient Clinical Outcome Measure: EQ-5D Visual Analogue Scale (VAS)

    Obtain clincal outcome data on patients treated using the X-PSI Knee System in primary TKA procedures. The EQ-5D VAS is a score to measure general quality of life. The general health state will be assessed on a patient self-reported Visual Analog Scale (VAS) where the endpoints are labelled 0 (worst imaginable health state) to 100 (best imaginable health state). The VAS is used as a quantitative measure of health outcome that reflects the patient's own judgement.

    Time frame: Baseline, 4-6 weeks and 1 year post-surgery

  4. Patient Clinical Outcome Measure: EQ-5D-3L Descriptive System

    The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems.

    Time frame: Baseline, 4-6 weeks and 1 year post-surgery

07

Results

Posted Oct 6, 2021
Limitations and caveats
The study was prematurely terminated due to slow enrloment. Only 3 subjects were operated with X-PSI. Out of the 3 subjects, 2 reached the final 1 year follow-up. Due to the very low number of subjects, no statistical analysis was conducted on the data.

Participant flow

Participant flow — Overall Study
MilestoneTotal Knee Arthroplasty
Started8
Completed2
Not completed6
Withdrew: Protocol violation5
Withdrew: The study was stopped before the patient reached the final 1 year follow-up1

Outcome measures

PrimaryMechanical Leg Alignment

Achievement of mechanical leg alignment in HKA frontal plane (± 3 degrees) with X-PSI Knee System is as accurate as with standard instrumentation at 4-6 weeks post operation. The X-PSI Knee System cohort will be compared with current literature (70% of cases within ± 3 degrees). No control group will be studied.

Time frame:
4-6 weeks post-surgery

No measurements were reported for this outcome.

SecondaryCost-effectiveness of the X-PSI Knee System Using an Efficiency Matrix

The cost-effectiveness of the X-PSI Knee System will be measured using an efficiency matrix where OR set-up time, surgery time and tray sterilization times will be collected and compared to conventional TKA procedures.

Time frame:
During surgery, immediate pre- and post-surgery processing time

No measurements were reported for this outcome.

Other pre-specifiedPatient Clinical Outcome Measure: Visual Analog Score Pain

Obtain clincal outcome data on patients treated using the X-PSI Knee System in primary TKA procedures. The pain level will be measured using a 10 cm long scale indicating no pain (0) and worst imaginable pain (10).

Time frame:
Baseline, 4-6 weeks and 1 year post-surgery
Reported as:
Mean · units on a scale
Patient Clinical Outcome Measure: Visual Analog Score Pain
units on a scaleTotal Knee Arthroplasty
Baseline8.2 ± 0.9
4-6 weeks post-surgery3.7 ± 2.4
1 year post-surgery1.1 ± 0.4
Other pre-specifiedPatient Clinical Outcome Measure: Oxford Knee Score

The Oxford Knee Score (OKS) is a 12-item patient-reported patient reported outcome specifically designed and developed to assess function and pain after total knee replacement (TKR) surgery (arthroplasty). The OKS provides a single summed score which reflects the severity of problems that the respondent has with their knee. Each question (item) is scored from 0 to 4 with 0 being the worst outcome and 4 being the best outcome. The scores are then summed to produce an overall score running from 0 (worst possible) to 48 (best outcome).

Time frame:
Baseline, 4-6 weeks and 1 year post-surgery
Reported as:
Mean · score on a scale
Patient Clinical Outcome Measure: Oxford Knee Score
score on a scaleTotal Knee Arthroplasty
Baseline18.3 ± 6.6
4-6 weeks post-surgery30.3 ± 5.3
1 year post-surgery45.0 ± 2.0
Other pre-specifiedPatient Clinical Outcome Measure: EQ-5D Visual Analogue Scale (VAS)

Obtain clincal outcome data on patients treated using the X-PSI Knee System in primary TKA procedures. The EQ-5D VAS is a score to measure general quality of life. The general health state will be assessed on a patient self-reported Visual Analog Scale (VAS) where the endpoints are labelled 0 (worst imaginable health state) to 100 (best imaginable health state). The VAS is used as a quantitative measure of health outcome that reflects the patient's own judgement.

Time frame:
Baseline, 4-6 weeks and 1 year post-surgery
Reported as:
Mean · score on a scale
Patient Clinical Outcome Measure: EQ-5D Visual Analogue Scale (VAS)
score on a scaleTotal Knee Arthroplasty
Baseline73.3 ± 24.9
4-6 weeks post-surgery63.3 ± 12.5
1 year post-surgery91.5 ± 3.5
Other pre-specifiedPatient Clinical Outcome Measure: EQ-5D-3L Descriptive System

The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems.

Time frame:
Baseline, 4-6 weeks and 1 year post-surgery
Reported as:
Number · participants
Patient Clinical Outcome Measure: EQ-5D-3L Descriptive System
participantsTotal Knee Arthroplasty
Baseline - patients reprting any problem (i.e some problems/ extreme problems) : Mobility2
Baseline - patients reprting any problem (i.e some problems/ extreme problems) : Self-Care1
Baseline - patients reprting any problem (i.e some problems/ extreme problems) : Usual Activities2
Baseline - patients reprting any problem (i.e some problems/ extreme problems) : Pain/Discomfort3
Baseline - patients reprting any problem (i.e some problems/ extreme problems) : Anxiety1
4- weeks post-surgery patients reprting any problem (i.e some problems/ extreme problems) : Mobility2
4- wks post-OP patients reprting any problem (i.e some problems/ extreme problems) : Self-Care0
4- wks post-OP patients reprting any problem (i.e some problems/ extreme problems): Usual Activities2
4- wks post-OP patients reprting any problem (i.e some problems/ extreme problems) : Pain/Discomfort3
4- wks post-OP patients reprting any problem (i.e some problems/ extreme problems) : Anxiety2
1 year post-OP patients reprting any problem (i.e some problems/ extreme problems) : Mobility0
1 year post-surgery patients reprting any problem (i.e some problems/ extreme problems) : Self-Care0
1 year post-OP patients reprting any problem (i.e some problems/ extreme problems): Usual Activities0
1 year post-OP patients reprting any problem (i.e some problems/ extreme problems) : Pain/Discomfort1
1 year post-OP patients reprting any problem (i.e some problems/ extreme problems) : Anxiety0

Adverse events

Collected over 1 year starting from day of surgery. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Total Knee Arthroplasty0/3 (0%)0/3 (0%)0/3 (0%)

Baseline characteristics

Baseline data collected and reported for those participants that underwent surgery with X-PSI Knee System

Age, Categorical
Age, Categorical(Participants)Total Knee Arthroplasty
<=18 years0
Between 18 and 65 years2
>=65 years1
Sex: Female, Male
Sex: Female, Male(Participants)Total Knee Arthroplasty
Female0
Male3
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Total Knee Arthroplasty
Region of Enrollment
Region of Enrollment(Participants)Total Knee Arthroplasty
Germany3
08

Study locations

4 sites
  • HELIOS Kliniken Mittelweser GmbH
    Nienburg, 31582, Germany
  • Knie Praxis Prof. Dr. Tibesku
    Straubing, 94315, Germany
  • Zuyderland Medical Park
    Sittard, 6162, Netherlands
  • Royal Bournemouth Hospital
    Bournemouth, BH7 7DW, United Kingdom
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2018 to primary completion in Dec 2019, 14 months.

Results were first posted in Oct 2021, 1 year 9 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2017
First posted
Sep 7, 2017
StartActual
Oct 5, 2018
Primary completionActual
Dec 20, 2019
CompletionActual
Nov 17, 2020
Results first posted
Oct 6, 2021
Last update
Oct 6, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03275246
Lead sponsor
Zimmer, GmbH
Responsible party
Sponsor
First posted
Sep 7, 2017
Start date
Oct 5, 2018
Primary completion
Dec 20, 2019
Completion
Nov 17, 2020
Results posted
Oct 6, 2021
Last update
Oct 6, 2021

Study contacts

Oliver Schaetti, PhD
study chair · Jr. Clinical Project Lead

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion